Almirall Enlists Absci’s AI Expertise For Dermatology Drug Discovery

 
• By Mandy Jackson

Deal Snapshot: In Almirall’s first de novo artificial intelligence drug discovery and development collaboration, the company will pay up to $650m to work with Absci on two dermatology candidates.

Artificial intelligence chip with the letters AI in the middle
Absci is focusing on drug discovery with its AI technology • Source: Shutterstock

More from Deals

More from Business